Increased levels of mir-34a, the second miRNA mostly upregulated in our miRNA-seq, have been described as an inductor of Th17 response by targeting FOXP3 in rheumatoid arthritis and systemic lupus erythematosus patients (Xie et al., 2019). The gene discussed is FOXP3; the disease is rheumatoid arthritis.